Literature DB >> 2412845

Possible involvement of substance P immunoreactive nerves in the mediation of nicotine-induced contractile responses in isolated guinea pig bronchus.

Y Kizawa, I Takayanagi.   

Abstract

Nicotine-induced contraction of the isolated guinea pig bronchial preparation was abolished by capsaicin and a substance P (SP) antagonist [( D-Arg1,D-Pro2,D-Trp7,9,Leu11]SP). Nicotine increased the release of immunoreactive SP from the preparations. The nicotine-evoked release of immunoreactive SP from the bronchial preparation was reduced by hexamethonium but not by tetrodotoxin. The results indicate that the responses to nicotine of the guinea pig bronchial preparation were mediated through the release of SP-like material(s), and that the nicotine-induced response may be produced through a process independent of the sodium action potential. In conclusion, the most likely site of action of nicotine in the isolated guinea pig bronchial preparation is the nicotinic receptor of SP immunoreactive nerves.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2412845     DOI: 10.1016/0014-2999(85)90079-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Role of primary sensory neurons in the central effects of nicotine.

Authors:  M Hajós; G Engberg
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  Nicotine-induced airway smooth muscle contraction: neural mechanisms involving the airway epithelium. Functional and histologic studies in vitro.

Authors:  H L Hahn; M Lang; S Bleicher; S Zwerenz; C Rausch
Journal:  Clin Investig       Date:  1992 Mar-Apr

3.  Bronchoconstriction and delayed rapid shallow breathing induced by cigarette smoke inhalation in anesthetized rats.

Authors:  L B Fang; R F Morton; A L Wang; L Y Lee
Journal:  Lung       Date:  1991       Impact factor: 2.584

4.  Mechanism of action of nicotine in isolated iris sphincter preparations of rabbit.

Authors:  T Hisayama; M Shinkai; I Takayanagi; S Morimoto; K Ishida
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.